{"id":"https://openalex.org/W2393516561","doi":null,"title":"CIK cells combined with TACE treatment of primary liver cancer randomized controlled study","display_name":"CIK cells combined with TACE treatment of primary liver cancer randomized controlled study","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2393516561","mag":"2393516561"},"language":"en","primary_location":{"id":"mag:2393516561","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-SCYX201210009.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764907195","display_name":"Sichuan Medical Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727549","host_organization_name":"Sichuan Medical Association","host_organization_lineage":["https://openalex.org/P4361727549"],"host_organization_lineage_names":["Sichuan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Sichuan Medical Journal","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103665494","display_name":"HU Jin-hua","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"HU Jin-hua","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103665494"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2011,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.65019713,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytokine-induced-killer-cells","display_name":"cytokine-induced killer cells","score":0.8669999837875366},{"id":"https://openalex.org/keywords/transarterial-chemoembolization","display_name":"transarterial chemoembolization","score":0.9330000281333923},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9739999771118164},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7129999995231628},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.7519999742507935},{"id":"https://openalex.org/keywords/survival-rate","display_name":"survival rate","score":0.8899999856948853}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9788166284561157},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6298110485076904},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6170703768730164},{"id":"https://openalex.org/C2776231280","wikidata":"https://www.wikidata.org/wiki/Q623031","display_name":"Liver cancer","level":3,"score":0.5962501764297485},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5829091668128967},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.5460801124572754},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5146637558937073},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.44832271337509155},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4129987359046936},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3825153112411499}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2393516561","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-SCYX201210009.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764907195","display_name":"Sichuan Medical Journal","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4361727549","host_organization_name":"Sichuan Medical Association","host_organization_lineage":["https://openalex.org/P4361727549"],"host_organization_lineage_names":["Sichuan Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Sichuan Medical Journal","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2068444146","https://openalex.org/W2003784754","https://openalex.org/W1553718404","https://openalex.org/W2353363439","https://openalex.org/W2387282943","https://openalex.org/W2355322326","https://openalex.org/W2036950999","https://openalex.org/W2528814359","https://openalex.org/W2367668473","https://openalex.org/W2522367417"],"abstract_inverted_index":{"Objective":[0],"This":[1],"study":[2],"evaluated":[3],"the":[4,26,70],"effect":[5],"of":[6,51,67],"CIK":[7,32,80],"cell":[8],"immunotherapy":[9,82],"combined":[10,78],"with":[11,79],"TACE":[12,27,30,46,77],"to":[13,39],"treat":[14],"liver":[15,86],"cancer.Methods":[16],"A":[17],"random":[18],"confirmed":[19],"118":[20],"cases":[21],"HCC":[22],"were":[23],"set":[24],"into":[25],"group":[28,47,63],"and":[29,60,89],"joint":[31],"group.Major":[33],"evaluation":[34],"after":[35],"treatment":[36],"is":[37],"time":[38],"disease":[40],"progression(TTP),and":[41],"1-year":[42],"follow-up,3-year":[43],"survival":[44,56,73],"rate.Results":[45],"TTP":[48,64],"was":[49,58,65,75],"average":[50,66],"4.7":[52],"months,and":[53,69],"1\u30013":[54,71],"year":[55,72],"rate":[57,74],"51.7%":[59],"11.6%.The":[61],"CIK-TACE":[62],"10.7":[68],"86.3%,46%.Conclusion":[76],"cells":[81],"can":[83],"better":[84],"control":[85],"tumor":[87],"lesions":[88],"prolong":[90],"survival.":[91]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2016-06-24T00:00:00"}